microRNAs are important players in head and neck carcinoma: a review

Joanna Janiszewska1, Marcin Szaumkessel, Krzysztof Szyfter

  • 1Institute of Human Genetics, Polish Academy of Sciences, Department of Environmental Mutagenesis, 60-479 Poznań, Poland.

Insights

Head and neck cancer treatment remains challenging, with limited success for surgery and chemotherapy. MicroRNAs (miRNAs) show promise as a targeted therapy for these tumors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Head and neck tumors have historically poor treatment outcomes.
  • Surgery and chemotherapy show limited efficacy due to tumor resistance.
  • Radiotherapy offers some progress, but targeted therapies are highly anticipated.

Purpose of the Study:

  • To review the current understanding of microRNAs (miRNAs) in head and neck cancers.
  • To explore the potential of miRNAs as diagnostic and prognostic tools.
  • To summarize the role of miRNAs in the molecular carcinogenesis of these malignancies.

Main Methods:

  • Comprehensive literature review of studies published after 2000.
  • Analysis of research on microRNA expression and function in head and neck malignancies.
  • Focus on squamous cell carcinomas of the head and neck.

Main Results:

  • MicroRNAs (miRNAs) have emerged as significant players in cancer research.
  • miRNAs exhibit high specificity and correlate with clinicopathological parameters.
  • Extensive investigations highlight their potential in understanding cancer development.

Conclusions:

  • MicroRNAs represent a promising avenue for targeted therapy in head and neck cancers.
  • Further research into miRNAs could lead to novel diagnostic and prognostic strategies.
  • Understanding miRNA roles is crucial for advancing head and neck cancer treatment.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...